Trial Profile
A Prospective, Multi-centre, Randomized Controlled, First in Man Study to Assess the Safety and Performance of the Passeo-18 Lux Paclitaxel Releasing PTA Balloon Catheter vs. the Uncoated Passeo 18 Balloon Catheter in Patients With Stenosis and Occlusion of the Femoropopliteal Arteries (BIOLUX P-I).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus First in man; Therapeutic Use
- Acronyms BIOLUX P-I
- Sponsors BIOTRONIK
- 04 Dec 2014 New trial record